ABOUT US INVESTMENT PORTFOLIOS OUR TEAM BOARD OF DIRECTORS INVESTMENT STRATEGY NEWS
CONTACT HOME

 

Logo - SLS Invest(Life Science Investments)

SLS Invest Portfolio
 
     

     
Action Pharma A/S

Action Pharma is a biotech company founded in year 2000 and located just north of Copenhagen, Denmark. Action Pharma pursues the discovery and development of drug candidates within cardiovascular diseases, inflammatory diseases and Type II diabetes. Action Pharma now has a pipeline of seven drug candidates of which two are in clinical development phase in Scandinavia and in the USA.

Go to website >>
 
     

     
AdvanDx Inc

AdvanDx is a molecular diagnostic company committed to provide the medical profession with advanced in vitro diagnostic kits, such as PNA FISH for rapid and simple pathogen identification in blood cultures and screening test for the prevention of hospital acquired infections, leading to improved therapy and better patient management.
AdvanDx was founded in 2002 by Mr. Thais T. Johansen, President and CEO, and Dr. Henrik Stender, Vice President of Research and Development

Go to website >>
 
     

     

Atlas Antibodies AB

Atlas Antibodies was founded by researchers led by Professor Mathias Uhlen at the Royal Institute of Technology (KTH) in Stockholm and the Rudbeck Laboratory, Uppsala University in Uppsala, Sweden. Atlas Antibodies will handle the production, marketing and sales of the antibody products developed and validated in the Human Proteome Resource (HPR) Center. The HPR Center is performing a systematic exploration of the human proteome with Affinity (Antibody) based Proteomics, combining high-throughput generation of affinity-purified (mono-specific) antibodies with protein profiling using tissue microarrays. In addition to antibodies generated from the HPR Center, Atlas aims to seek patents for biomarkers showing up during the sequencing of the human protein atlas, and thus potentially expand its business into diagnostics and therapeutics.

Go to website >>

 
     

     
Biopheresis Technologies GmbH

Biopheresis Technologies is developing an innovative immuno/biological therapy, utilizing a patented medical device product, initially focused on cancer indications.  The company was founded and is incorporated in the US, but is operationally centered in Heidelberg, Germany,  where, through its wholly-owned German GmbH subsidiary, the company is planning post-marketing clinical studies in metastatic breast cancer patients.

Go to website >>
 
     

     
Doxa AB

Doxa is an Uppsala-based dental company, developing, producing and marketing bioceramic dental products. Ceramir® Crown & Bridge, the first in a range of planned bioceramic dental products from Doxa, is an advanced dental cement used for the permanent fixture of dental crowns and bridges. Ceramir® Crown & Bridge, which is CE-marked and FDA-approved, binds well with dental substances such as metal, conventional ceramics and special ceramics such as aluminium oxide and zirconium dioxide. The product, which has performed extremely well in clinical trials, was launched in Sweden in November 2009 and will be launched in a couple of more countries in 2010.



Go to website >>

 
     

     

Exiqon A/S

Exiqon A/S is a biotechnology company providing solutions for life scientists through the application of two core technologies; LNA™ - Locked Nuclei Acid and AQ-Link™ - Anthraquinone Photochemistry.

Go to website >>

 
     

     
Gyros AB

Gyros AB is a Swedish-based company located in Uppsala. The company’s automated platform, Gyrolab®, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins.
Gyrolab enables assays to be conducted with a significantly reduced background, increased dynamic range and with higher throughput. All this is achieved using only nanoliter volumes of reagents and sample. More data can be generated in less time and with higher precision, consequently improving productivity and effectiveness. Applications span the entire spectrum for immunoassays and Gyrolab is now firmly established as the preferred solution for pharmacokinetic (PK) assays in the development of therapeutic proteins.
Many major pharmaceutical companies and service providers— CMOs/CROs—have already implemented multiple Gyrolab platforms to boost their drug development process and to meet increasing regulatory demands on testing.

Go to website >>
 
     

     

Light Sciences Oncology, Inc.

Light Sciences Oncology, Inc. (LSO) was incorporated in late 2004 to develop and commercialize the technology of Light Sciences Corporation in the field of oncology. The Seattle-based company is targeting the treatment of primary liver cancer, liver metastases from colorectal cancer and other solid tumors, by the means of a light activated drug. LSO has initiated its pivotal clinical study in patients with liver cancer which is among the most malignant of cancers and afflicts more than one million people per year worldwide.

Go to website >>

 
     

     

Medical Vision R&D AB

Medical Vision R&D AB was founded in 2002 and focuses on endoscopy. The mission is to improve the quality of patient care and reduce health care cost through products built on safe and proven technology. The company develops and produces a broad range of products used during endoscopic procedures including the Double®Pump which provides automated pressure and flow control thereby facilitating surgeon procedures in arthroscopy

Go to website >>

 
     

     
   

MetaCure Limited

MetaCure Limited, a Bermuda company founded in 2003, is developing minimally invasive solutions for today’s most pressing global epidemics, type-2 diabetes and obesity. MetaCure's approach is based on a proprietary technology also used for the treatment of chronic heart failure. TANTALUS® is a trademark of MetaCure Limited and it has already achieved the CE mark and been implanted in 96 patients to date.

Go to website >>

 
     

     
   
Nuevolution A/S

Nuevolution A/S is a drug discovery company based on its proprietary Chemetics™ technologies to rapidly identify multiple drug candidates to virtually any target in very short time.

Go to website >>

 
     

     
Oncolog Medical

ONCOlog Medical is a medical technology company developing unique products and solutions for safer and more cost-effective radiation therapy of various tumor diseases. The product portfolio includes patient handling and positioning systems, treatment table tops and quality assurance systems.

Go to website >>
 
     


     
OxThera

OxThera is a clinical stage biotechnology company based in Sweden and Florida. The company develops products, based on its cell- and enzyme based proprietary technologies, for metabolic disorders based on excess oxalate from endogenous and exogenous sources. OxThera will market and sell its orphan drug products to treat and prevent hyperoxaluria and kidney stones in indications such as Primary and Enteric Hyperoxaluria.

Go to website >>
 
     

     
PreciSense A/S

PreciSense A/S is developing a novel, minimally invasive measurement device of blood glucose for diabetic patients. The global market for diabetes is large and growing rapidly. A key component of modern diabetes care is to maintain metabolic control, which is facilitated by increased awareness of glucose levels. The PreciSense glucose monitoring system is currently entering clinical trials and aims to target both the discrete and continuous markets.

Go to website >>
 
     

     
Sanos Bioscience A/S

Sanos Bioscience A/S is a spin-out from Nordic Bioscience A/S focusing on development of GLP-2 for the treatment of osteoporosis.

Go to website >>
 
     

 

 
Sophion Bioscience A/S

Sophion Bioscience A/S is committed to providing advanced products and integrated solutions for high-throughput ion channel characterization of living cells. Their products and solutions fulfill a growing demand from the pharmaceutical industry for faster screening methods with much higher information content than today. This enables faster development of new and better drugs.

Go to website >>
 

 


KA Intressenter Portfolio
 
     

     
Cellectricon

Cellectricon develops and sells platforms for cell-based drug discovery based on unique competences in microfabrication, microfluidics, biosensors and cell biology. Live cellular analysis enables researchers to monitor drug candidate efficacy on a real-time basis as the drug enters the cell and alters its function. Cellectricon’s first products are used today by the vast majority of the leading players in the pharmaceutical industry.

Go to website >>
 
     

     

NsGene

NsGene is committed to developing novel biologics for the treatment of neurological diseases and NsGene’s R&D activities are focused on a proprietary encapsulated cell biodelivery technology and proprietary neurotrophic proteins. Based on the EC BiodeliveryTM platform, NsGene develops implantable medicinal products that secrete therapeutic agents to the central nervous system to treat neurological diseases with high needs for efficacious treatments, including Alzheimer’s disease, Parkinson’s disease, and intractable epilepsy.

Go to website >>

 
     

     

Phasein

Phasein develops, markets and manufactures ultra-compact mainstream and sidestream multigas analyzers, which can be integrated into patient monitors, anesthesia delivery systems and ventilators.

Go to website >>

 
     

     

WILEX

WILEX is a biopharmaceutical company, founded in 1997 by a team of physicians and oncologists from the Technical University of Munich. The mission is to develop drugs with a low side effect profile and targeted treatment of different types of cancer as well as diagnostic agents for specific detection of tumours.

Wilex is based in Munich and is listed at the Frankfurt Stock Exchange.

Go to website >>